Literature DB >> 27114331

Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old).

Erica E Marsh1, Lia A Bernardi2, Marissa L Steinberg2, Peter J de Chavez3, Jenny A Visser4, Mercedes R Carnethon3, Donna D Baird5.   

Abstract

OBJECTIVE: To characterize normative antimüllerian hormone (AMH) levels and ascertain which factors are associated with AMH in a large cohort of reproductive-age women.
DESIGN: Cross-sectional study.
SETTING: Not applicable. PATIENT(S): A total of 1,654 African-American women (AAW) ages 23-34 at recruitment. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Serum AMH measured using an ultrasensitive ELISA. RESULT(S): The median AMH was 3.18 ng/mL, and there was a significant, but nonlinear, relationship between age and AMH, with levels peaking at age 25. As AMH was not normally distributed, log transformation was performed and used for all analyses. In a multivariable age-adjusted model, body mass index, current use of hormonal contraception, and history of a thyroid condition were inversely associated with AMH, while history of abnormal menstrual bleeding and menstrual cycles longer than 35 days were positively associated with AMH. CONCLUSION(S): While age is correlated with AMH, it accounts for only a portion of the variation seen. This study adds valuable information to the existing literature on normative AMH levels in young reproductive-age women. While our findings fill a critical data gap for ovarian reserve in AAW, the insights gained will be of benefit for all women.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMH; African-American women; ovarian reserve

Mesh:

Substances:

Year:  2016        PMID: 27114331      PMCID: PMC4975664          DOI: 10.1016/j.fertnstert.2016.04.008

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  46 in total

Review 1.  Ovarian aging: mechanisms and clinical consequences.

Authors:  F J Broekmans; M R Soules; B C Fauser
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.

Authors:  M Dólleman; M J Faddy; J van Disseldorp; Y T van der Schouw; C M Messow; B Leader; P H M Peeters; A McConnachie; S M Nelson; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2013-03-18       Impact factor: 5.958

3.  Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Authors:  S L Broer; M J C Eijkemans; G J Scheffer; I A J van Rooij; A de Vet; A P N Themmen; J S E Laven; F H de Jong; E R Te Velde; B C Fauser; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

4.  Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women.

Authors:  Christine L Cook; Yong Siow; Amy G Brenner; Mary E Fallat
Journal:  Fertil Steril       Date:  2002-01       Impact factor: 7.329

5.  Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve.

Authors:  Erkan Buyuk; David B Seifer; Edward Illions; Richard V Grazi; Harry Lieman
Journal:  Fertil Steril       Date:  2011-05-06       Impact factor: 7.329

6.  Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

Authors:  A La Marca; S Giulini; A Tirelli; E Bertucci; T Marsella; S Xella; A Volpe
Journal:  Hum Reprod       Date:  2006-10-27       Impact factor: 6.918

7.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

Authors:  Pascal Pigny; Emilie Merlen; Yann Robert; Christine Cortet-Rudelli; Christine Decanter; Sophie Jonard; Didier Dewailly
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

8.  A Prospective, Ultrasound-Based Study to Evaluate Risk Factors for Uterine Fibroid Incidence and Growth: Methods and Results of Recruitment.

Authors:  Donna D Baird; Quaker E Harmon; Kristen Upson; Kristen R Moore; Christie Barker-Cummings; Susan Baker; Tracy Cooper; Ganesa Wegienka
Journal:  J Womens Health (Larchmt)       Date:  2015-09-03       Impact factor: 2.681

Review 9.  The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.

Authors:  Simone L Broer; Ben Willem J Mol; Dave Hendriks; Frank J M Broekmans
Journal:  Fertil Steril       Date:  2008-03-05       Impact factor: 7.329

10.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

View more
  9 in total

1.  Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women.

Authors:  Lia A Bernardi; Mercedes R Carnethon; Peter J de Chavez; Deborah E Ikhena; Lisa M Neff; Donna D Baird; Erica E Marsh
Journal:  Obesity (Silver Spring)       Date:  2016-12-07       Impact factor: 5.002

2.  Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women.

Authors:  Leah Hawkins Bressler; Lia A Bernardi; Peter John D De Chavez; Donna D Baird; Mercedes R Carnethon; Erica E Marsh
Journal:  Am J Obstet Gynecol       Date:  2016-07-11       Impact factor: 8.661

3.  Intrauterine, Infant, and Childhood Factors and Ovarian Reserve in Young African American Women.

Authors:  Kristen Upson; Helen B Chin; Erica E Marsh; Donna D Baird
Journal:  J Womens Health (Larchmt)       Date:  2019-01-14       Impact factor: 2.681

Review 4.  Ovarian Reserve Testing: A Review of the Options, Their Applications, and Their Limitations.

Authors:  Nicole D Ulrich; Erica E Marsh
Journal:  Clin Obstet Gynecol       Date:  2019-06       Impact factor: 2.190

5.  MOTHER Study: A Multicenter Observational, Retrospective Study to Determine Coorelation Between Physical CHaracteristics and Ovarian REserve Markers in Sub-feRtile Women.

Authors:  Charmila Ayyavoo; Asha Baxi; Gorakh Mandrupkar; Sonia Malik; Jayam Kannan; Deepak Goenka; Nagesh Kumar; Monica Singh; Sharda Kulkarni; Kanchan Murarka Agarwal; Sonam Baxi
Journal:  J Obstet Gynaecol India       Date:  2021-05-08

6.  Association between uterine fibroids and antimüllerian hormone concentrations among African American women.

Authors:  Lia A Bernardi; Anne Waldo; Veronica J Berrocal; Lauren A Wise; Erica E Marsh
Journal:  Fertil Steril       Date:  2022-01-31       Impact factor: 7.329

7.  Early-life Farm Exposure and Ovarian Reserve in a US Cohort of Women.

Authors:  Kristen Upson; Clarice R Weinberg; Hazel B Nichols; Gregg E Dinse; Aimee A D'Aloisio; Dale P Sandler; Donna D Baird
Journal:  Epidemiology       Date:  2021-09-01       Impact factor: 4.860

8.  Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels.

Authors:  Lia A Bernardi; Marissa Steinberg Weiss; Anne Waldo; Quaker Harmon; Mercedes R Carnethon; Donna D Baird; Lauren A Wise; Erica E Marsh
Journal:  Fertil Steril       Date:  2021-03-19       Impact factor: 7.490

Review 9.  Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A Review.

Authors:  Alexander M Kotlyar; David B Seifer
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-09       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.